← Back to the wire

Can AI help scientists identify promising drug candidates?

AnnouncementBenchmarkNov 18, 2026

GPT-6.2 Astra earned 84.5% of available credit on MedChemBench at the xhigh setting, ahead of GPT-6 Astra (83.3%), GPT-6.1 Sol (82.0%), and GPT-5.6 Sol (58.2%). The benchmark contains 99 problems drawn from 117 papers and patents and tests medicinal chemistry reasoning across four components: structure reconstruction, scientific reasoning, compound ranking and selection, and property prediction. Models performed best at reconstructing molecular structures; compound selection and numerical property prediction proved harder.

Receipt № 29981 source · awaiting confirmation ◐

Evidence

1source· awaiting independent confirmation

No score is assigned. Sources and their independence are shown in the citation chain below.

Citation chain · 1 source

01med
openai.comBloghttps://openai.com/index/introducing-medchembench/This is the benchmark's own launch announcement, providing the task design, the four evaluated components, and the official model comparison results at the xhigh reasoning setting.
PRIMARY
GPT-5.6 SolModelGPT-6 AstraModelGPT-6.1 SolModelGPT-6.2 AstraModel
Canonical: https://openai.com/index/introducing-medchembench/